SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 501.94 |
| Enterprise Value ($M) | 366.82 |
| Book Value ($M) | 194.10 |
| Book Value / Share | 2.74 |
| Price / Book | 2.59 |
| NCAV ($M) | 193.09 |
| NCAV / Share | 2.72 |
| Price / NCAV | 2.60 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -0.45 |
| Return on Assets (ROA) | -0.47 |
| Return on Equity (ROE) | -0.53 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 17.26 |
| Current Ratio | 17.26 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 209.63 |
| Assets | 210.64 |
| Liabilities | 16.54 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.43 |
| Operating Income | -83.51 |
| Net Income | -88.45 |
| Earnings Per Share Basic And Diluted | n/a |
| Earnings Per Share Diluted | n/a |
| Earnings Per Share Basic | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | -75.81 |
| Cash from Investing | 13.73 |
| Cash from Financing | 86.11 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G/A | State Street Corp | 12.20 | 752.53 | |
| 13G | Millennium Management Llc | 5.40 | ||
| 13G/A | Nuveen Asset Management, LLC | 2.88 | ||
| 13G/A | Teachers Advisors, Llc | 2.88 | ||
| 13G/A | Tiaa Cref Investment Management Llc | 2.88 | -47.11 | |
| 13G | Ameriprise Financial Inc | 7.79 | ||
| 13G/A | Avidity Partners Management LP | 0.00 | -100.00 | |
| 13G/A | Tang Capital Partners Lp | 5.10 | 1.83 | |
| 13G/A | Vanguard Group Inc | 6.65 | 41.05 | |
| 13G/A | Janus Henderson Group Plc | 0.00 | -99.99 | |
| 13G | BlackRock Inc. | 7.50 | 320.37 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 488,271 | 1,890,520 | 25.83 | |
| 382,809 | 640,483 | 59.77 | |
| 443,660 | 1,047,837 | 42.34 | |
| 450,721 | 719,962 | 62.60 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| ADMA – ADMA Biologics, Inc. | ALIM – Alimera Sciences, Inc. |
| ALPN – Alpine Immune Sciences, Inc. | ANIP – ANI Pharmaceuticals, Inc. |
| APGE – Apogee Therapeutics, Inc. |
Financial data and stock pages provided by
Fintel.io